The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases: a review of the underlying mechanisms
- PMID: 38769198
- DOI: 10.1007/s10787-024-01492-1
The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases: a review of the underlying mechanisms
Abstract
Neurodegenerative diseases are part of the central nervous system (CNS) disorders that indicate their presence with neuronal loss, neuroinflammation, and increased oxidative stress. Several pathophysiological factors and biomarkers are involved in this inflammatory process causing these neurological disorders. The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is an inflammation element, which induced transcription and appears to be one of the important players in physiological procedures, especially nervous disorders. NF-κB can impact upon series of intracellular actions and induce or inhibit many inflammation-related pathways. Multiple reports have focused on the modification of NF-κB activity, controlling its expression, translocation, and signaling pathway in neurodegenerative disorders and injuries like Alzheimer's disease (AD), spinal cord injuries (SCI), and Parkinson's disease (PD). Curcumin has been noted to be a popular anti-oxidant and anti-inflammatory substance and is the foremost natural compound produced by turmeric. According to various studies, when playing an anti-inflammatory role, it interacts with several modulating proteins of long-standing disease signaling pathways and has an unprovocative consequence on pro-inflammatory cytokines. This review article determined to figure out curcumin's role in limiting the promotion of neurodegenerative disease via influencing the NF-κB signaling route. Preclinical studies were gathered from plenty of scientific platforms including PubMed, Scopus, Cochrane, and Google Scholar to evaluate this hypothesis. Extracted findings from the literature review explained the repressing impact of Curcumin on the NF-κB signaling pathway and, occasionally down-regulating the cytokine expression. Yet, there is an essential need for further analysis and specific clinical experiments to fully understand this subject.
Keywords: Alzheimer’s disease; Herbal medicine; Neuroinflammation; Parkinson’s disease; Phytopharmacology.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?Int J Biol Sci. 2024 Jan 27;20(4):1332-1355. doi: 10.7150/ijbs.90982. eCollection 2024. Int J Biol Sci. 2024. PMID: 38385077 Free PMC article. Review.
-
Nuclear Factor Kappa B: A Nobel Therapeutic Target of Flavonoids Against Parkinson's Disease.Comb Chem High Throughput Screen. 2024 Jan 18. doi: 10.2174/0113862073295568240105025006. Online ahead of print. Comb Chem High Throughput Screen. 2024. PMID: 38243959
-
Curcumin potentiates the anti-inflammatory effects of Tehranolide by modulating the STAT3/NF-κB signaling pathway in breast and ovarian cancer cell lines.Inflammopharmacology. 2023 Oct;31(5):2541-2555. doi: 10.1007/s10787-023-01281-2. Epub 2023 Jul 14. Inflammopharmacology. 2023. PMID: 37452228
-
Protective effects of curcumin against traumatic brain injury.Biomed Pharmacother. 2022 Oct;154:113621. doi: 10.1016/j.biopha.2022.113621. Epub 2022 Aug 30. Biomed Pharmacother. 2022. PMID: 36055110 Review.
-
Curcumin modulates TLR4/NF-κB inflammatory signaling pathway following traumatic spinal cord injury in rats.J Spinal Cord Med. 2015 Mar;38(2):199-206. doi: 10.1179/2045772313Y.0000000179. Epub 2014 Jan 3. J Spinal Cord Med. 2015. PMID: 24621048 Free PMC article.
References
-
- Ahmadi M, Agah E, Nafissi S, Jaafari MR, Harirchian MH, Sarraf P, Faghihi-Kashani S, Hosseini SJ, Ghoreishi A, Aghamollaii V, Hosseini M, Tafakhori A (2018) Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics 15:430–438 - PubMed - PMC - DOI